Results 281 to 290 of about 691,914 (362)

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Clascoterone is an androgen receptor inhibitor approved for the treatment of acne vulgaris in patients 12 years of age and older. Here, we report results of 5 phase 1 studies that assessed the pharmacokinetics (PK), safety, and skin irritation and sensitization potential of clascoterone cream 1% in healthy participants and patients with acne ...
Andrea Francesco Daniele Di Stefano   +8 more
wiley   +1 more source

Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
P2Y12 inhibitor selection involves numerous factors, including CYP2C19 genetics, since evidence demonstrates reduced clopidogrel efficacy in patients with decreased or no function CYP2C19 variants. In 2020, Indiana University health embedded interruptive clinical decision support (CDS) alerts in the electronic health record (EHR) to recommend ...
Ashley N. Springer   +14 more
wiley   +1 more source

Solute-Vehicle-Skin Interactions and Their Contribution to Pharmacokinetics of Skin Delivery. [PDF]

open access: yesPharmaceutics
Tapfumaneyi P   +6 more
europepmc   +1 more source

Experimental model for percutaneous tracheostomy training. [PDF]

open access: yesBraz J Otorhinolaryngol
Namur CS   +4 more
europepmc   +1 more source

The Safety of Ultrasound-Guided Needle Approaches for Patellar Tendinopathy: A Theoretical Cadaveric Model. [PDF]

open access: yesJ Funct Morphol Kinesiol
Calderón-Díez L   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy